Hi, what are you looking for?
Two Israeli medtech firms, NeuroSense and Compugen, this week have each made new announcements. NeuroSense Therapeutics, an Israeli company developing treatments for severe neurodegenerative...
– The collaboration will focus on immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. – Compugen Ltd. (Nasdaq: CGEN;...
In recent years, cancer research and treatment centers have been awash with a wave of new, exciting developments, under the umbrella of “immunotherapy, ”...
– Compugen and Bayer will collaborate on development and commercialization of antibody-based cancer immunotherapies. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen – /By Ilan...
Researchers at Tel Aviv University (TAU) said that for the first time in history, they succeeded in encoding a toxin produced by bacteria into...
Today I present to you my predictions for Israel’s medical achievements that will take place in the forthcoming new Jewish Year of 5776. They...
As Israel’s biggest company Teva strives to get even bigger by swallowing up rival Mylan for more than $40 billion, further down the food...
In the 18th Jan 2015 edition of Israel’s good news, the highlights include: · Two Israeli biotechs are at the forefront of...
In the 11th Jan 2015 edition of Israel’s good news, the highlights include: · In a chance discovery, Israeli scientists have found...
– Discount Investment and IDB Development are sharply down in an otherwise stable market. – Following the cancellation by Adama Holding Ltd. (TASE:ADMA.B1) of...